 | • レポートコード：MRC-IM30304 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年58億ドルであった世界の日光性角化症治療市場規模が2027年には79億ドルに達し、予測期間中、年平均5.27％成長すると予測しています。本調査レポートでは、日光性角化症治療の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（処方、OTC）分析、薬剤種類別（フルオロウラシル、イミキモド、ジクロフェナク、その他）分析、流通チャネル別（病院薬局、ドラックストア・小売薬局、オンラインストア）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S,Sun Pharmaceutical Industries Ltd.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の日光性角化症治療市場規模：種類別 - 処方日光性角化症治療の市場規模 - OTC日光性角化症治療の市場規模 ・世界の日光性角化症治療市場規模：薬剤種類別 - フルオロウラシルの市場規模 - イミキモドの市場規模 - ジクロフェナクの市場規模 - その他の日光性角化症治療市場規模 ・世界の日光性角化症治療市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - ドラックストア・小売薬局チャネルの市場規模 - オンラインストアチャネルの市場規模 ・世界の日光性角化症治療市場規模：地域別 - 北米の日光性角化症治療市場規模 - アジアの日光性角化症治療市場規模 - 欧州の日光性角化症治療市場規模 - 中南米の日光性角化症治療市場規模 - 中東・アフリカの日光性角化症治療市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global actinic keratosis treatment market size reached US$ 5.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2027, exhibiting a growth rate (CAGR) of 5.27% during 2022-2027.
Actinic keratosis, also known as solar keratosis, refers to a skin condition that develops on the sun-exposed areas of the body. It causes rough, scaly patches to appear on the hands, arms, lips, scalp, and other body parts that can further develop into a skin cancer called squamous cell carcinoma. Some of the commonly used treatments to remove actinic keratosis include cryotherapy, curettage, laser therapy, and photodynamic therapy. At present, the considerably expanding healthcare infrastructure and increasing need for preventive strategies for cancer are positively influencing the demand for actinic keratosis treatment worldwide.
Actinic Keratosis Treatment Market Trends:
The increasing prevalence of actinic keratosis due to ozone layer depletion and excessive sun exposure represents one of the key factors fueling the growth of the market. Additionally, the rising incidences of cancer, coupled with the escalating demand for minimally invasive (MI) procedures, is strengthening the market growth. Furthermore, leading manufacturers are introducing medications for the treatment of actinic keratosis in the form of cream and gel, which is impelling the market growth. Apart from this, numerous public and private groups are focusing on conducting campaigns to generate awareness about available treatments for actinic keratosis across the globe. This, along with significant investments in the research and development (R&D) activities to develop novel therapies with improved efficacy, convenient dosage, and reduced costs, is creating a favorable market outlook. The market is also driven by the introduction of topical treatment that reduces the risk of scarring. This treatment is also used for treating a wide area of visible and invisible lesions on the skin. Besides this, favorable reimbursement policies are anticipated to fuel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global actinic keratosis treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug type and distribution channel.
Breakup by Type:
Prescription
OTC
Breakup by Drug Type:
Fluorouracil
Imiquimod
Diclofenac
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S and Sun Pharmaceutical Industries Ltd.
Key Questions Answered in This Report:
How has the global actinic keratosis treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global actinic keratosis treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global actinic keratosis treatment market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Actinic Keratosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Prescription
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 OTC
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Fluorouracil
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Imiquimod
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diclofenac
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Stores and Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Almirall SA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Biofrontera Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 BioLineRx Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Cipher Pharmaceuticals Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Galderma SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Hill Dermaceuticals Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 LEO Pharma A/S
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
Figure 2: Global: Actinic Keratosis Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Actinic Keratosis Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Actinic Keratosis Treatment Market: Breakup by Type (in %), 2021
Figure 5: Global: Actinic Keratosis Treatment Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Actinic Keratosis Treatment Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Actinic Keratosis Treatment Market: Breakup by Region (in %), 2021
Figure 8: Global: Actinic Keratosis Treatment (Prescription) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Actinic Keratosis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Actinic Keratosis Treatment (OTC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Actinic Keratosis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Actinic Keratosis Treatment (Fluorouracil) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Actinic Keratosis Treatment (Fluorouracil) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Actinic Keratosis Treatment (Imiquimod) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Actinic Keratosis Treatment (Imiquimod) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Actinic Keratosis Treatment (Diclofenac) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Actinic Keratosis Treatment (Diclofenac) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Actinic Keratosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Actinic Keratosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Actinic Keratosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Actinic Keratosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Actinic Keratosis Treatment Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Actinic Keratosis Treatment Industry: SWOT Analysis
Figure 76: Global: Actinic Keratosis Treatment Industry: Value Chain Analysis
Figure 77: Global: Actinic Keratosis Treatment Industry: Porter's Five Forces Analysis
